Effect of OPG-HSP70 on serological parameters of CIA mouse model and its correlation with efficacy
XIA Sisi1,2 ZHAO Wenming2 RONG Yujia2
1.Department of Rheumatology and Immunology, Beijing Chao-Yang Hospital, Capital Medical University, Beijing 100020, China;
2.Department of Immunology, School of Basic Medicine, Capital Medical University, Beijing 100069, China;
3.Laboratory Blood Bank, the 731 Hospital Affiliated to China Aerospace Science and Industry Group, Beijing 100074, China
Abstract：Objective To investigate the relationship between serum parameters and disease status in collagen-induced arthritis (CIA) mice after OPG-HSP70 treatment. Methods Forty-four male DBA/1 mice were divided into OPG-HSP70 treatment group (n = 20), OPG treatment group (n = 12) and model control group (n = 12). CIA model was induced by intradermal immunization of bovine CⅡ in the tail root. OPG or OPG-HSP70 fusion protein was injected intraperitoneally every other day after arthritis, whereas model control group was injected with the same amount of PBS solution. The mice were sacrificed after 4 weeks of administration, the arthritis index was evaluated, and the relative gray value of bone was measured by Micro-CT. The serum was collected to detect Ca2+, RANKL and type Ⅱ collagen (CⅡ) antibodies. The linear regression was analysis between arthritis index and bone density values and serum data. Results Compared with the model control group, arthritis index of OPG-HSP70 treatment group was significantly reduced (P ＜ 0.01), the BMD value increased obviously (P ＜ 0.05), the CⅡ antibodies lower significantly (P ＜ 0.01). However, OPG did not significantly improve inflammation and bone damage. Linear regression analysis showed that, the serum Ca2+ and RANKL were negatively correlated with the bone density value (r = -0.582, -0.588, all P ＜ 0.01); while the serum CⅡ antibody level was positively correlated with the arthritis index (r = 0.892, P ＜ 0.01). Compared with the OPG treatment group, serum anti-OPG antibodies were significantly lower in the OPG-HSP70 treatment group 1, 2, 3, 4 weeks after administration (P ＜ 0.01). Conclusion The OPG-HSP70 fusion protein adds anti-inflammatory effect and reduces immunogenicity, and the protection of CIA mice is better than that of OPG.
夏思思1，2 赵文明2 荣雨佳3. OPG-HSP70对CIA小鼠模型血清学参数的影响及其与疗效的相关性分析[J]. 中国医药导报, 2019, 16(31): 14-17.
XIA Sisi1,2 ZHAO Wenming2 RONG Yujia2. Effect of OPG-HSP70 on serological parameters of CIA mouse model and its correlation with efficacy. 中国医药导报, 2019, 16(31): 14-17.
[1] Nava-Valdivia CA，Saldana-Cruz AM，Corona-Sanchez EG，et al. Polymorphism rs2073618 of the TNFRSF11B （OPG） Gene and Bone Mineral Density in Mexican Women with Rheumatoid Arthritis [J]. J Immunol Res 2017，2017（2）：1-8.
[2] van Tuyl LH，Voskuyl AE，Boers M，et al. Baseline RANKL：OPG ratio and markers of bone and cartilage degradation predict annual radiological progression over 11 years in rheumatoid arthritis [J]. Ann Rheum Dis，2010，69（9）：1623-1628.
[3] El-Saka MH，Madi NM，Shahba A. The possible role of heat shock protein-70 induction in collagen-induced arthritis in rats [J]. Physiol Int，2019，106（2）：128-139.
[4] Eden WV. Immune tolerance therapies for autoimmune diseases based on heat shock protein T-cell epitopes [J]. Philos Trans R Soc Lond B Biol Sci，2018，373（1738）：20160531.
[5] Poole JA，Thiele GM，Janike K，et al. Combined Collagen-Induced Arthritis and Organic Dust-Induced Airway Inflammation to Model Inflammatory Lung Disease in Rheumatoid Arthritis [J]. J Bone Miner Res，2019，34（9）：1733-1743.
[6] Wang T，Qiao H，Zhai Z，et al. Plumbagin Ameliorates Collagen-Induced Arthritis by Regulating Treg/Th17 Cell Imbalances and Suppressing Osteoclastogenesis [J]. Front Immunol，2018，9：3102.
[7] Bar-Yoseph H，Pressman S，Blatt A，et al. Infliximab-Tumor Necrosis Factor Complexes Elicit Formation of Anti-drug Antibodies [J]. Gastroenterology，2019，157（5）：1338-1351.e8.
[8] Swisher JF，Feldman GM. The many faces of FcgammaRI：implications for therapeutic antibody function [J]. Immunol Rev，2015，268（1）：160-174.
[9] Cao W，Niu M，Tong Y，et al. Depleting the carboxy-terminus of human Wnt5a attenuates collagen-induced arthritis in DBA/1 mice [J]. Biochem Biophys Res Commun，2018，504（4）：679-685.
[10] Brand DD，Latham KA，Rosloniec EF. Collagen-induced arthritis [J]. Nat Protoc，2007，2（5）：1269-1275.
[11] Du Y，Tong Y，Mei W，et al. A Truncated IL-17RC Peptide Ameliorates Synovitis and Bone Destruction of Arthritic Mice [J]. Adv Healthc Mater，2016，5（22）：2911-2921.
[12] Romas E，Sims NA，Hards DK，et al. Osteoprotegerin reduces osteoclast numbers and prevents bone erosion in collagen-induced arthritis [J]. Am J Pathol，2002，161（4）：1419-1427.
[13] Yuan H，Qian H，Liu S，et al. Therapeutic role of a vaccine targeting RANKL and TNF-alpha on collagen-induced arthritis [J]. Biomaterials，2012，33（32）：8177-8185.
[14] Simonet WS，Lacey DL，Dunstan CR，et al. Osteoprotegerin：a novel secreted protein involved in the regulation of bone density [J]. Cell，1997，89（2）：309-319.
[15] Popova V，Vazhev Z，Geneva-Popova M，et al. Comparison of RANKL expression，inflammatory markers，and cardiovascular risk in patients with acute coronary syndrome with and without rheumatoid arthritis [J]. Rheumatol Int，2019，39（10）：1723-1732.
[16] Yang H，Liu W，Zhou X，et al. The association between RANK，RANKL and OPG gene polymorphisms and the risk of rheumatoid arthritis：a case-controlled study and meta-analysis [J]. Biosci Rep，2019，39（6）. pii：BSR201 82356.
[17] Olotu F，Adeniji E，Agoni C，et al. An update on the discovery and development of selective heat shock protein inhibitors as anti-cancer therapy [J]. Expert Opin Drug Discov，2018，13（10）：903-918.
[18] Liu C，Chaudhry MT，Zhao D，et al. Heat shock protein 70 protects the quail cecum against oxidant stress，inflammatory injury，and microbiota imbalance induced by cold stress [J]. Poult Sci，2019，98（11）：5432-5445.
[19] Hang K，Ye C，Chen E，et al. Role of the heat shock protein family in bone metabolism [J]. Cell Stress Chaperones，2018，23（6）：1153-1164.
[20] Konstantinova EV，Chipigina NS，Shurdumova MH，et al. Heat Shock Protein 70 kDa as a Target for Diagnostics and Therapy of Cardiovascular and Cerebrovascular Diseases [J]. Curr Pharm Des，2019，25（6）：710-714.
2019, Vol. 16 
京公网安备 11010502046598号